Germany: Europe's Leading Player In Nanotechnology
Research and Markets has announced the addition of 'Nanotechnology in Germany 2007' to their offering.
Sep 25th, 2007
Read more
Subscribe to our Nanotechnology Business News feed
Leading IC Engineers to Gather in Albany at SEMATECH Workshop on 3D Chips
An International SEMATECH-sponsored workshop will bring leading engineers to Albany, NY, Oct. 11-12 to share insights on design and thermal challenges for next-generation, three-dimensional integrated circuits (3D ICs).
Sep 25th, 2007
Read moreWallSt.net Announces Upcoming Interview with CEO of BioSante Pharmaceuticals
Stephen Simes, chief executive officer of BioSante Pharmaceuticals, Inc. will be featured in an exclusive interview with www.wallst.net scheduled for September 26 at 10:30 a.m. EDT.
Sep 24th, 2007
Read moreNanoLogix Inc. to Present at EBW Expo and Conference 2007
NanoLogix, Inc. a nano-biotechnology company announced it will be an exhibitor and participant in the "Energy from Biomass and Waste" Expo at the David L. Lawrence Convention Center in Pittsburgh, Pennsylvania September 25-27, 2007.
Sep 24th, 2007
Read moreBioNanomatrix Receives New NCI Grant to Support Development of Chip-Based Nanofluidics Systems for C(...)
STTR grant will support development of advanced sample sorting capabilities and enhancements in chip design for applications in cancer diagnostics and research.
Sep 24th, 2007
Read moreOntario - The Ultimate Destination For Innovation
Ontario Centres of Excellence (OCE) Inc. will hold its Annual General Meeting tomorrow, September 25.
Sep 24th, 2007
Read moreFEI Introduces FEI.com for Owners Featuring FEI Connect
New service enables online networking and sharing of application expertise and best practices.
Sep 24th, 2007
Read moreKonarka Names Dan Williams Vice President of Product and Business Development
Konarka Technologies, Inc., an innovator in development and commercialization of Power Plastic, a material that converts light to energy, today announced that Dan Williams has joined the company as vice president of product and business development.
Sep 24th, 2007
Read moreArrowhead Subsidiary, Insert Therapeutics, Awarded Patent for Cyclosert(TM) Camptothecin, the Company's Lead Oncology Candidate
Insert Therapeutics, Inc., a majority-owned subsidiary of Arrowhead Research Corporation, announced today the issuance of a patent covering its lead oncology product, IT-101.
Sep 24th, 2007
Read moreVulvox Develops Composites That Maintain The Sticky Properties of Carbon Nanotubes
The Vulvox discovery could eliminate the necessity of using photolithography to make nanotubes in tufts patterns, bringing the potential cost down tremendously.
Sep 24th, 2007
Read moreInnovations in Cardiovascular Disease Management: Latest Surgical Procedures, Drugs and Medical Devices
Research and Markets has announced the addition of Innovations in Cardiovascular Disease Management: Latest Surgical Procedures, Drugs and Medical Devices to their offering.
Sep 21st, 2007
Read moreIndia Releases Incentive Program Guidelines to Attract Nanotechnology Manufacturing
The government of India released the "Special Incentive Package Scheme" aimed at encouraging investments for setting up semiconductor fabrication facilities and other micro and nanotechnology manufacturing industries in India.
Sep 21st, 2007
Read more'Commercializing Nanotechnologies' Is The Most Comprehensive Report Yet Published On Nanotechnology (...)
Research and Markets has announced the addition of 'Commercialising Nanotechnologies' to their offering.
Sep 21st, 2007
Read moreKylin Therapeutics Signs Collaboration with Fort Dodge Animal Health, a Division of Wyeth
Kylin to use its pRNA technology to help develop new RNAi therapeutics to treat cancer.
Sep 21st, 2007
Read moreResearch and Markets: Government Policies and Initiatives in Nanotechnology Worldwide 2007
Research and Markets has announced the addition of Government Policies and Initiatives in Nanotechnology Worldwide 2007 to their offering.
Sep 21st, 2007
Read moreHospitals See Infection Rates More Than Halved, Patient Stays Shortened By 27 Percent In New Study Announced By I-Flow
An innovative medical device is responsible for reducing surgical site infection rates by more than 50 percent and for significantly shortening hospital stays when compared with traditional narcotic pain care.
Sep 20th, 2007
Read more